Skip to main content

PsyKey Inc Announces Beta Testing of its Telemental Health App Aimed to Aid in North America’s $330 Billion Mental Health Crisis

CARSON CITY, NV / ACCESSWIRE / September 7, 2022 / CECORS, INC. (OTC PINK:CEOS) ("CeCors" or the "Company"), through its wholly-owned subsidiary PsyKey Inc. is pleased to announce it has completed the beta version of its Telehealth App PSYKEY LIVE.

Accessibility to quality mental health support through qualified care providers can be an overwhelming task. According to, an estimated $280 billion was spent on mental health services in the United States in 2020. In Canada, over the past 20 years, mental health costs have increased by 646%, bringing the economic burden to an estimated $51 billion per year, according to the Centre for Addiction and Mental Health (CAMH). This cost includes health care, lost productivity, and reductions in health-related quality of life.

The PSYKEY LIVE App was created to streamline accessing mental health support services. The app is designed with ease of use and convenience at the forefront of importance, providing individuals direct access to mental health support providers via video conferencing, live chatting and more. The comprehensive App platform allows users to view profiles of care providers, schedule and track appointments, and create individual private health profiles. These profiles can house users' private health records, medication use information, and any critical notes individuals may wish to disclose to the providers they choose. The PSYKEY LIVE App is now ready for real-world beta testing and will be utilized in various settings to fine-tune and optimize its functionality.

Digital interaction and Telehealth have become more prevalent in recent years, especially under the health restrictions the world is currently dealing with. Not only does digital Telehealth offer convenience to all, but it also affords PSYKEY LIVE the ability to offer support to rural, remote, and high-risk communities across the country, bridging the gap and providing real accessibility.

About PsyKey Inc.

PsyKey Inc. Is an innovative wellness company that specializes in the development and commercialization of mycology-based entheogenic, adaptogenic, and nootropic ingredients and formulations. From functional to psychedelic PsyKey believes in the magic of mushrooms.

As part of its optimal wellness strategy, PsyKey understands the importance of access to support services and healthcare professionals. Management is continuously engaged in the development of tools that will aid in removing barriers and providing inclusivity.

For further information:

Publicly traded company (OTC PINK:CEOS)
Follow us on Twitter:

Forward-Looking Statements:

Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences to include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency, and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.

SOURCE: CeCors, Inc.

View source version on

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.